Cargando…
Short-Interval, Low-Dose Peptide Receptor Radionuclide Therapy in Combination with PD-1 Checkpoint Immunotherapy Induces Remission in Immunocompromised Patients with Metastatic Merkel Cell Carcinoma
Merkel cell carcinoma (MCC) is a neuroendocrine skin cancer of the elderly, with high metastatic potential and poor prognosis. In particular, the primary resistance to immune checkpoint inhibitors (ICI) in metastatic (m)MCC patients represents a challenge not yet met by any efficient treatment modal...
Autores principales: | Aicher, Alexandra, Sindrilaru, Anca, Crisan, Diana, Thaiss, Wolfgang, Steinacker, Jochen, Beer, Meinrad, Wiegel, Thomas, Scharffetter-Kochanek, Karin, Beer, Ambros J., Prasad, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323617/ https://www.ncbi.nlm.nih.gov/pubmed/35890361 http://dx.doi.org/10.3390/pharmaceutics14071466 |
Ejemplares similares
-
Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre
por: Thaiss, Wolfgang, et al.
Publicado: (2023) -
Changes of Radiation Treatment Concept Based on (68)Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
por: Bottke, Dirk, et al.
Publicado: (2021) -
18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting
por: Eberhardt, Nina, et al.
Publicado: (2022) -
Interobserver variability, detection rate, and lesion patterns of (68)Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy
por: Miksch, Jonathan, et al.
Publicado: (2020) -
A Novel S100A8/A9 Induced Fingerprint of Mesenchymal Stem Cells associated with Enhanced Wound Healing
por: Basu, Abhijit, et al.
Publicado: (2018)